GlobalData, Nov 2010, Pages: 208
and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- GenzymeCorporation - Brief company overview including business description, key information and facts, and its
Global Markets Direct, Nov 2010, Pages: 208
and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- GenzymeCorporation - Brief company overview including business description, key information and facts, and its
GlobalData, April 2011, Pages: 53
– Company’s Lifesciences Financial Deals and Alliances
GenzymeCorporation, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
GenzymeCorporation, Pharmaceuticals & Healthcare, Deals By Type
Global Markets Direct, Nov 2011, Pages: 36
by Global Markets Direct’s team.
Scope
- Applied Genetic Technologies Corporation - Brief Applied Genetic Technologies Corporation overview including business description, key information and facts
Global Industry Analysts, Inc., Jan 2011, Pages: 354
Indicator
Genzyme Unveils New Mutation Analysis Test
Orchid BioSciences Introduces New Testing Kit
Focus Diagnostics Introduces GenomEx(TM) Service
Relative Genetics Introduces Y-chromosome haplogroup
Global Industry Analysts, Inc., Oct 2011, Pages: 373
------------------------------------------ - Alcon, Inc.
- Allergan, Inc.
- Anika Therapeutics, Inc.
- Bioniche Pharma USA, LLC.
- Genzyme Biosurgery
- Q-Med AB
- Seikagaku Corporation. Collagen and HA-Based Biomaterials - Global Strategic Business
Global Industry Analysts, Inc., Sep 2008, Pages: 321
The global outlook series on Biotechnology provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers a bird’s eye view
Global Markets Direct, Nov 2010, Pages: 61
releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Targeted Genetics Corporation - Brief company overview including business
Industry Experts, April 2011, Pages: 266
Orthopaedics Inc.
Dow Chemical
Dow Corning Corporation
Dupont (EI) De Nemours
Eastman Chemical Company
ETEX Corporation
Exactech, Inc
Exxonmobil Chemical Company
GenzymeCorporation
Integra Lifesciences Holdings
GlobalData, April 2011, Pages: 47
and Alliances
Life Technologies Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Life Technologies Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
Life
GlobalData, Aug 2011, Pages: 46
:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis
GlobalData, Nov 2011, Pages: 17
Data’s Perfinity Biosciences, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed
GlobalData, Aug 2011, Pages: 45
and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats
GlobalData, Sep 2011, Pages: 41
for treating acute myocardial infarction, bone marrow/hematopoetic stem cell transplantation, ischemic stroke and autoimmune disease. The company has collaborated with reputed corporate, academic, and clinical
GlobalData, Aug 2011, Pages: 49
2011
Kensey Nash Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2005 to YTD 2011 GenzymeCorporation
Wright Medical Technology, Inc.
Cook Medical Incorporated
Covidien plc
Johnson
Global Markets Direct, March 2011, Pages: 42
and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific
Global Industry Analysts, Inc., Oct 2010, Pages: 274
., Kinetic Biosystems, Inc., Maxygen Inc, Codexis Inc., Novozymes A/S, Seravac Biotech (Pty) Ltd, Specialty Enzymes & Biochemicals Co., and Verenium Corporation. Market data and analytics are derived from
